Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding
whether to initiate or continue treatment with this medication. While mostly associated with …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Amiodarone is a class III antiarrhythmic drug widely used for the treatment of both
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …

Amiodarone chlorhydrate is a diiodated benzofuran derivative used to treat cardiac rhythm
abnormalities. Hepatotoxicity is a relatively uncommon side effect of amiodarone and …

Fatal amiodarone-induced hepatotoxicity: a case report and literature review. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

Background: The prevalence of hepatotoxicity after longterm oral amiodarone therapy in
Chinese patients with or without elevated liver enzymes at baseline is unknown. Hypothesis …

Background Amiodarone is a highly effective treatment for supraventricular and ventricular
tachyarrhythmia; however, it could be associated with several serious adverse effects …

What is known and objective Amiodarone, a commonly used class III antiarrhythmic agent
notable for a relatively long half‐life of up to 6 months and its pronounced adverse effect …

This cross-sectional, retrospective study was designed to evaluate the current clinical
applications and acute hepatotoxicity of intravenous amiodarone administration at a hospital …

Amiodarone is a benzofuran class III antiarrhythmic drug used to treat a wide spectrum of
ventricular tachyarrhythmias. The parenteral formulation is prepared in polysorbate 80 …